Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Archives of Pathology & Laboratory Medicine|August 1, 2013
An unusual case of Philadelphia chromosome-positive chronic myelogenous leukemia with trisomy 19 presenting with megakaryoblastosis and myelofibrosisNika Aljinovic, Agata M Bogusz, Sibel Kantarci, et al.
Lab on a Chip|January 21, 2016
A fully integrated paperfluidic molecular diagnostic chip for the extraction, amplification, and detection of nucleic acids from clinical samplesNatalia M Rodriguez, Winnie S Wong, Lena Liu, et al.
Cancer Biology & Therapy|February 2, 2011
Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic markerRajan Dewar, Sing-Tsung Chen, Heather Yeckes-Rodin, et al.
Archives of Pathology & Laboratory Medicine|February 28, 2015
Best practices in diagnostic immunohistochemistry: workup of cutaneous lymphoid lesions in the diagnosis of primary cutaneous lymphomaRajan Dewar, Aleodor Alexandru Andea, Joan Guitart, et al.
Plos One|October 25, 2013
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cellsOctavian Bucur, Andreea Lucia Stancu, Ioana Goganau, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|October 22, 2019
Combined Tumors in Hematolymphoid Neoplasms: Case Series of Histiocytic and Langerhans Cell Sarcomas Arising From Low-Grade B-Cell LymphomaStephanie L Skala, Jing C Ye, Jennifer Stumph, et al.
Urology|January 13, 2023
The Diagnosis of Urinary Tract Infections Using a Novel At-home Testing Protocol to Enhance Telemedicine: A Retrospective AnalysisAndrew Korman, Siddharth Ramanathan, Nathan Shen, et al.
Cancer Research|August 6, 2009
Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressorsZainab Jagani, Keli Song, Jeffery L Kutok, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2011
VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonizationJoyce T O'Connell, Hikaru Sugimoto, Vesselina G Cooke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma ViabilityCarlos Murga-Zamalloa, Delphine C M Rolland, Avery Polk, et al.
Pageof 3